Primary Mucosa-Associated Lymphoid Tissue Lymphoma of the Salivary Glands: A Multicenter Rare Cancer Network Study

Yavuz Anacak(Ege University), Mahmut Özsahin(Centre Hospitalier Universitaire Vaudois), Anna Kowalczyk(University Clinical Centre), Sidney P. Kadish(University of Massachusetts Chan Medical School), Serra Kamer(Ege University), P. Poortmans(University of Antwerp), Damien C. Weber(University Hospital of Geneva), Anna Lucas Calduch(Institut Català d'Oncologia), Ron Epelbaum(University of Bern), A.M. Mamusa, Robert C. Miller(Mayo Clinic), Nikos Constantinou(Theageneio General Hospital), Ye‐Xiong Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Nuran Beşe(Turkcell (Turkey))
International Journal of Radiation Oncology*Biology*Physics
November 15, 2010
10.1016/j.ijrobp.2010.09.046
Cited by 68

Related Papers

Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
|The Lancet|2017|401
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Testicular Cancer Survivorship: Research Strategies and Recommendations
|JNCI Journal of the National Cancer Institute|2010|289